Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 7, 2023
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
Mon, February 6, 2023
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
Jason Bednar Maintained (XRAY) at Hold with Increased Target to $35 on, Feb 6th, 2023
Jason Bednar of Piper Sandler, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Hold with Increased Target from $29 to $35 on, Feb 6th, 2023.
Jason has made no other calls on XRAY in the last 4 months.
There are 3 other peers that have a rating on XRAY. Out of the 3 peers that are also analyzing XRAY, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brandon Vazquez of "William Blair" Upgraded from Sell to Hold on, Thursday, January 12th, 2023
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $34 on, Wednesday, November 16th, 2022
This is the rating of the analyst that currently disagrees with Jason
- Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Tuesday, November 15th, 2022
